- HOME >
- For Researchers >
- Product Search >
- Search Result >
- #11041 Anti-Human G-CSF (4-12-2) Mouse IgG MoAb
Product Search
#11041 Anti-Human G-CSF (4-12-2) Mouse IgG MoAb
- Intended Use:
- Research reagents
- Application:
- IHC
- Package Size1:
- 1 mL
- Package Size2:
- 0.1mL
- Note on Application Abbreviations
- IHC:Immunohistochemistry
※ The product indicated as "Research reagents" in the column Intended Use cannot be used
for diagnostic nor any medical purpose.
※ The datasheet listed on this page is sample only. Please refer to the datasheet
enclosed in the product purchased before use.
Product Overview
Product Overview
Product Code | 11041 |
---|---|
Product Name | Anti-Human G-CSF (4-12-2) Mouse IgG MoAb |
Intended Use | Research reagents |
Application | IHC |
Species | Human |
Immunizing antigen | Recombinant Human G-CSF |
Source | Mouse-Mouse hybridoma (X63 - Ag 8.653 × BALB/c mouse spleen cells) |
Clone Name | 4-12-2 |
Subclass | IgG1 |
Purification Method | Affinity purified with Protein A |
Package Form | Lyophilized product from PBS containing 1 % BSA and 0.05 % NaN3 |
Storage Condition | 2 - 8℃ |
Poisonous and Deleterious Substances | Applicable |
Cartagena | Not Applicable |
Package Size 1 | 1 mL |
Package Size 2 | 0.1mL |
Remarks1 | The commercial use of products without our permission is prohibited. Please make sure to contact us and obtain permission. |
Product Description
Product Description
G-CSF (Granulocyte Colony Stimulating Factor) is cytokine which accelerates differentiation and multiplication of neutrophilic precursor cell. It is reported that G-CSF is produced in such as fibroblast and endothelial cell, and that the multiplication of G-CSF is accelerated in some solid tumor which has such as leukemia and G-CSF receptor. fig.1 Lung Cancer (squamous cell carcinoma), 2ug/mL, x200 fig.1 were kindly provided by Prof. Toshimitsu Suzuki, Dept. of Second Pathology, Fukushima Medical University, Japan. fig.2 Human Breast Cancer (Spindle Cell Carcinoma), x200 fig.3 Human Breast Cancer (Spindle Cell Carcinoma), x400 fig.2,3 were kindly provided by Dr. Yoshinori Matsuki, Department of Pathological Diagnosis, Mitsui Memorial Hospital
References
References
- Colony-stimulating factors detected in tumor cells and voided urine are potential prognostic markers for patients with muscle-invasive bladder cancer undergoing radical cystectomy. Morizawa Y et al. Res Rep Urol. 2018 Sep 21;10:103-111.PMID: 30288389
- Granulocyte-colony stimulating factor producing rectal cancer. Takahashi H et al. World J Surg Oncol. 2008 Jun 29;6:70.PMID: 18588705
Note: Retrieve by PMID number in displayed by abstract: http://www.ncbi.nlm.nih.gov